Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGIODYNAMICS, INC.

(ANGO)
  Report
Delayed Quote. Delayed Nasdaq - 12/07 04:00:00 pm
26.49 USD   +2.40%
12/06ANGIODYNAMICS INC : Other Events (form 8-K)
AQ
11/03ANGIODYNAMICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
10/18INSIDER SELL : Angiodynamics
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
25.49(c) 26.55(c) 25.64(c) 25.87(c) 26.49(c) Last
196 487 116 240 208 768 279 926 147 752 Volume
-1.01% +4.16% -3.43% +0.90% +2.40% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 314 M - -
Net income 2022 -16,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -62,6x
Yield 2022 -
Sales 2023 338 M - -
Net income 2023 -9,31 M - -
Net Debt 2023 - - -
P/E ratio 2023 -114x
Yield 2023 -
Capitalization 1 024 M 1 024 M -
Capi. / Sales 2022 3,26x
Capi. / Sales 2023 3,03x
Nbr of Employees 800
Free-Float 94,5%
More Financials
Company
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular... 
More about the company
Ratings of AngioDynamics, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about ANGIODYNAMICS, INC.
12/06ANGIODYNAMICS INC : Other Events (form 8-K)
AQ
11/03ANGIODYNAMICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
10/18INSIDER SELL : Angiodynamics
MT
10/15Health Care Stocks Easing Slightly in Late Trade
MT
10/15Health Care Stocks Advancing With Rising Friday Markets
MT
10/15ANGIODYNAMICS : Canaccord Genuity Upgrades AngioDynamics to Buy From Hold, Lifts Price Tar..
MT
09/30ANGIODYNAMICS : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
09/30ANGIODYNAMICS : rsquo; Fiscal 2022 First Quarter Financial Results
PU
09/30Health Care Stocks Closing Slightly Lower After Early Gains
MT
09/30ANGIODYNAMICS : Books Fiscal Q1 Adjusted Loss; Raises Outlook For Fiscal 2022 Net Sales; S..
MT
09/30ANGIODYNAMICS : Books Fiscal Q1 Adjusted Loss; Raises Outlook For Fiscal 2022 Net Sales
MT
09/30ANGIODYNAMICS : Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance (For..
PU
09/30ANGIODYNAMICS : Fiscal Q1 Earnings Snapshot
AQ
09/30ANGIODYNAMICS : Earnings Flash (ANGO) ANGIODYNAMICS Posts Q1 Revenue $77M, vs. Street Est ..
MT
09/30ANGIODYNAMICS : Earnings Flash (ANGO) ANGIODYNAMICS Reports Q1 Loss $-0.02, vs. Street Est..
MT
More news
News in other languages on ANGIODYNAMICS, INC.
10/15Les actions du secteur de la santé en légère baisse en fin de séance
10/15Les actions du secteur de la santé progressent grâce à la hausse des marchés du vendred..
09/30Les actions du secteur de la santé clôturent en légère baisse après des gains initiaux
09/30AngioDynamics enregistre une perte ajustée au premier trimestre de l'exercice fiscal et..
09/30Earnings Flash (ANGO) ANGIODYNAMICS affiche un chiffre d'affaires de 77 millions de dol..
More news
Analyst Recommendations on ANGIODYNAMICS, INC.
More recommendations
Chart ANGIODYNAMICS, INC.
Duration : Period :
AngioDynamics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANGIODYNAMICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 26,49 $
Average target price 34,50 $
Spread / Average Target 30,2%
EPS Revisions
Managers and Directors
James Christopher Clemmer President, Chief Executive Officer & Director
Stephen A. Trowbridge Chief Financial Officer & Executive Vice President
Howard W. Donnelly Independent Non-Executive Chairman
David D. Helsel SVP-Global Operations, Research & Development
Kim L. Seabury Senior Vice President-Information Technology